BackRani Therapeutics Holdings Overview

Rani Therapeutics Holdings Receivables

Rani Therapeutics Holdings's receivables is $2M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.04M
↑ 11244.44% YoYΔ $2.02M vs prior year quarter

Peer trimmed avg / median

Loading

Rani Therapeutics Holdings Receivables History

Loading

Rani Therapeutics Holdings vs. peers: Receivables Comparison

Loading

Rani Therapeutics Holdings Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rani Therapeutics Holdings (RANI) FAQ

As of the most recent data (June 2026), RANI shows a receivables of $2M. That compares with $18K in the prior-year period — up 11244.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RANI's receivables is now $2M (was $18K) — a 11244.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Rani Therapeutics Holdings is outperforming or lagging.

Tracking RANI's receivables over time shows whether Rani Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $2M That compares with $18K in the prior-year period — up 11244.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Rani Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $2M) with ownership activity and broader fundamentals.

Rani Therapeutics Holdings's receivables is $2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.